Dr Reddy's announces launch of Sildenafil tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a

RELATED ARTICLES

bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

This followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, a company statement said here.

The Revatio brand had US sales of approximately $38.67 million for the most recent twelve months ending September 2012, according to IMS Health.

Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes, the release said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • Government must give up majority ownership in loss making PSU banks

    After four years of braving economic slowdown and provisioning for rising non performing assets (NPAs), public sector banks are in urgent of capital.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

BK Chaturvedi

Cooperative federalism and governance

Improving relations between the states and the Centre to improve ...

Kuruvilla Pandikattu SJ

Reason drives religion, science

Both religion and science are driven by reason, claims Rama ...

Gautam Gupta

Retailers have it tough, thanks to e-commerce

For the past few months our focus has been on ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture